Navigation Links
Amgen to Present at the Goldman Sachs Global Healthcare Conference
Date:6/8/2009

THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will present at the Goldman Sachs Global Healthcare Conference on Wednesday, June 10, 2009 at the Grand Hyatt, New York City, N.Y., beginning at 9:00 a.m. Eastern Time. Roger M. Perlmutter, Amgen's Executive Vice President of Research & Development, will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    John Shutter, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
2. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
3. Amgen Highlights Data to Be Presented at ASCO
4. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
5. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
6. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
7. Amgen Announces Webcast of 2009 First Quarter Financial Results
8. Amgen to Present at the Barclays Capital Global Healthcare Conference
9. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
10. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Falls Church, VA (PRWEB) , ... ... ... Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdclineval                  , How will the ...
(Date:3/23/2017)... ... March 23, 2017 , ... News Advisory/Interview Opportunity , After six years ... major victory in Europe for public health and the environment and is calling on ... scientific research and the overwhelming support of European citizens, the European Union (EU) will, ...
(Date:3/23/2017)... , ... March 23, 2017 , ... “My Journey Through ... experience with an infinitely more profound faith of God’s promise of Heaven for His ... Jr., who spends each day with his wife, three children and six grandchildren living ...
(Date:3/23/2017)... ... March 23, 2017 , ... “The Trainer”: an ... published author, Scotty, a fiction writer with an active imagination and an enthusiasm for ... book follows the tale of Wild Bill Hart, who sat looking at the thirty-three ...
(Date:3/22/2017)... ... , ... Death anxiety is unconscious and needs understanding and non-judgmental support in ... write the book titled “ As Good as Goodbyes Get ” (published by Balboa ... she was experiencing at the bedside of patients who were dying. The book centers ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... March 23, 2017 The ... landscape with the top five players accounting for ... These companies are Stryker Sustainability Solutions, Ethicon (Johnson ... Inc., and VANGUARD AG. Despite the high level ... is witnessing the prevalence of fierce competition among ...
(Date:3/23/2017)... 23, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that it has acquired Agalimmune Ltd., a private UK-based ... of a $6 million upfront payment, of which $3 million ... future payments may be made based on development and commercial ... ...
Breaking Medicine Technology: